Optimal cutoffs for low skeletal muscle mass related to cardiovascular risk in adults: The Korea National Health and Nutrition Examination Survey 2009–2010
The possible association between low skeletal muscle mass and cardiovascular disease (CVD) risk factors necessitates estimation of muscle mass even in subjects with normal body mass index (BMI). This study was aimed to investigate optimal cutoffs for skeletal muscle mass reflecting CVD risk factors and to evaluate the relationship between skeletal muscle mass and CVD risk factors in the general population and in subjects with normal BMI using these cutoffs. This cross-sectional study analyzed data from the Korea National Health and Nutrition Examination Survey 2009–2010. We enrolled 5120 men and 6559 women aged ≥20 years. Skeletal muscle index (SMI) was defined as the weight-adjusted appendicular skeletal muscle mass measured by dual-energy X-ray absorptiometry. Using receiver operating characteristic curve analyses, SMI cutoffs associated with CVD risk factors were determined. Lower SMI was significantly associated with an increased prevalence of CVD risk factors. The first cutoffs in men and women were 32 and 25 %, respectively, and the second cutoffs were 30 and 23.5 %. Subjects in stage I and stage II SMI categories showed increased prevalence and risk for several CVD risk factors. These tendencies persisted in the association between cardiometabolic characteristics and SMI even in subjects with normal BMI. Using cutoffs of low skeletal muscle mass reflecting CVD risk factors, lower skeletal muscle mass was associated with increased prevalence and risk of several CVD risk factors. A higher prevalence of cardiometabolic abnormalities was observed among subjects with normal BMI but low skeletal muscle mass.
KeywordsCardiovascular disease Duel energy X-ray absorptiometry Sarcopenia Skeletal muscle mass Skeletal muscle index
We greatly appreciate the participants in the 2009–2010 Korea National Health and Nutrition Examination Survey.
Conflict of interest
The authors declare that they have no conflict of interest or funding source.
- 2.T.N. Kim, M.S. Park, S.J. Yang, H.J. Yoo, H.J. Kang, W. Song, J.A. Seo, S.G. Kim, N.H. Kim, S.H. Baik, D.S. Choi, K.M. Choi, Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 33, 1497–1499 (2010)PubMedCentralCrossRefPubMedGoogle Scholar
- 3.Y.S. Kim, Y. Lee, Y.S. Chung, D.J. Lee, N.S. Joo, D. Hong, Ge Song, H.J. Kim, Y.J. Choi, K.M. Kim, Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J. Gerontol. A 67, 1107–1113 (2012)CrossRefGoogle Scholar
- 4.A.J. Cruz-Jentoft, J.P. Baeyen, J.M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F.C. Martin, J.P. Michel, Y. Rolland, S.M. Schneider, E. Topinková, M. Vandewoude, M. Zamboni, European Working Group on Sarcopenia in older people., Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing 39, 412–423 (2010)PubMedCentralCrossRefPubMedGoogle Scholar
- 8.A. Romero-Corral, V.K. Somers, J. Sierra-Johnson, R.J. Thomas, M.L. Collazo-Clavell, J. Korinek, T.G. Allison, J.A. Batsis, F.H. Sert-Kuniyoshi, F. Lopez-Jimenez, Accuracy of body mass index in diagnosing obesity in the adult general population. Int. J. Obes. 32, 959–966 (2008)CrossRefGoogle Scholar
- 9.A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, S. Hendriksen, J.W. Kusek, F. Van Lente, Chronic kidney disease epidemiology collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 145, 247–254 (2006)CrossRefPubMedGoogle Scholar
- 11.J.Y. Oh, Y.J. Yan, B.S. Kim, J.H. Kang, Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form. J. Korean Acad. Fam. Med. 28, 532–541 (2007)Google Scholar
- 16.S. Lim, J.H. Kim, J.W. Yoon, S.M. Kang, S.H. Choi, Y.J. Park, K.W. Kim, J.Y. Lim, K.S. Park, Jang HC Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean longitudinal study on health and aging (KLoSHA). Diabetes Care 33, 1652–1654 (2010)PubMedCentralCrossRefPubMedGoogle Scholar
- 18.Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285, 2486–2497 (2001)CrossRefGoogle Scholar
- 21.S.O. Chin, S.Y. Rhee, S. Chon, Y.C. Hwang, I.K. Jeong, S. Oh, K.J. Ahn, H.Y. Chung, J.T. Woo, S.W. Kim, J.W. Kim, Y.S. Kim, H.Y. Ahn, Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PLoS One 8, e60119 (2013)PubMedCentralCrossRefPubMedGoogle Scholar
- 26.S.J. Baek, G.E. Nam, K.D. Han, S.W. Choi, S.W. Jung, A.R. Bok, Y.H. Kim, K.S. Lee, B.D. Han, Kim DH Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination Survey. J. Endocrinol. Invest. 37, 247–260 (2014)CrossRefPubMedGoogle Scholar
- 28.T.N. Kim, S.M. Park, K.I. Lim, S.J. Yang, H.J. Yoo, H.J. Kang, W. Song, J.A. Seo, S.G. Kim, N.H. Kim, S.H. Baik, D.S. Choi, K.M. Choi, Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Res. Clin. Pract. 93, 285–291 (2011)CrossRefPubMedGoogle Scholar